Halozyme Therapeutics
HALO
#2264
Rank
$6.30 B
Marketcap
$49.50
Share price
-0.24%
Change (1 day)
50.14%
Change (1 year)

Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Volume in USD (price x number of shares), data since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$1.93 M-92.41%
2023$25.5 M-15.59%
2022$30.2 M38.39%
2021$21.82 M-6.23%
2020$23.27 M-44.23%
2019$41.74 M591.9%
2018$6.03 M-64.48%
2017$16.98 M-5.65%
2016$17.99 M-13.05%
2015$20.7 M-7.81%
2014$22.45 M140.61%
2013$9.33 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$28.5 M$0.59 B๐Ÿ‡บ๐Ÿ‡ธ USA
$13.91 M$0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA
$54.05 M$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
$29.8 M$76.77 M๐Ÿ‡ซ๐Ÿ‡ท France
$10.32 M$48.18 M๐Ÿ‡บ๐Ÿ‡ธ USA
$11.22 M$14.13 M๐Ÿ‡บ๐Ÿ‡ธ USA